Epithelial–mesenchymal transitions (EMTs) generate hybrid phenotypes with an enhanced
ability to adapt to diverse microenvironments encountered during the metastatic spread …

Pancreatic cancer is one of the leading causes of cancer death worldwide. Its high mortality
rate has remained unchanged for years. Radiotherapy and surgery are considered standard …

Although many genes and miRNAs have been reported for various cancers, pancreatic
cancer's specific genes or miRNAs have not been studied precisely yet. Therefore, we have …

Pancreatic cancer is a devastating disease with a high mortality rate and a lack of effective
therapies. The challenges associated with early detection and the highly aggressive nature …

Background The detection and quantification of circulating tumour cells (CTCs) in pancreatic
cancer (PC) has the potential to provide prognostic information. The aim of this review was …

Pancreatic ductal adenocarcinoma (PDAC) is an invasive and aggressive cancer that
remains a major threat to human health across the globe. Despite advances in cancer …

Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy
characterised by late diagnosis and poor prognosis, with current diagnostic and prognostic …

Abstract Background Immune checkpoint inhibitors (ICIs) can improve survivals of metastatic
triple negative breast cancer (mTNBC); however, we still seek circulating blood biomarkers …

OBJECTIVES: Breast cancer (BC) is the most common neoplasm in women. Biopsy of
metastatic lesions is recommended to confirm estrogen receptor (ER), progesterone …

BACKGROUND: Ductal adenocarcinoma of the pancreas is the fourth most common
cancerassociated cause of death in the Western world. The presence of circulating tumor …